These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17272936)

  • 1. [Recommendations for estrogen and progesterone substitution in climacteric and postmenopause].
    Birkhauser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2007; 47(1):45-8. PubMed ID: 17272936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):53-7. PubMed ID: 16452821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for hormonal contraception. 34. Workshop of the "Zurich Discussion Circle", April 2005].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):58-63. PubMed ID: 16452822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for hormone treatment with estrogen and progesterone in the climacteric and postmenopausal periods. 37th Workshop of the Zurich Discussion Group , September 2006].
    Birkhauser M; Braendle W; Kiesel L; Kuhl H; Neulen J; Thaler CJ
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):38-46. PubMed ID: 18209499
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for replacement of estrogens and progestins in climacteric and in postmenopause. 25. Arbeitstreffen des "Zürcher Gesprächskreises", November 2000].
    Birkhäuser M; Braendle W; Breckwoldt M; Keller PJ; Kuhl H; Runnebaum B
    Gynakol Geburtshilfliche Rundsch; 2001; 41(1):12-5. PubMed ID: 11423732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone substitution in climacteric and postmenopause. Consensus report of the Austrian Menopause Society].
    Metka M; Heytmanek G; Enzelsberger H; Kurz C; Huber J; Brandstätter N; Tscherne G; Tabarelli M; Holzer G
    Wien Med Wochenschr; 1992; 142(5-6):94-5. PubMed ID: 1615684
    [No Abstract]   [Full Text] [Related]  

  • 8. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
    Easton BT
    J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
    [No Abstract]   [Full Text] [Related]  

  • 9. New warnings emerge for estrogen plus progesterone. Two studies confirm major cardiovascular risks outweigh minor health benefits for postmenopausal women.
    Heart Advis; 2011 Oct; 14(10):5. PubMed ID: 23019711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estrogen substitution therapy in climacteric: should progesterone be omitted in hysterectomized women?].
    Huber J
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):257-61. PubMed ID: 1860657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma.
    Pettersson B; Adami HO; Persson I; Bergström R; Lindgren A; Johansson ED
    Acta Obstet Gynecol Scand; 1986; 65(1):81-7. PubMed ID: 3716786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
    Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
    Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal treatment of climacteric complaints. A controlled, double-blind comparative study between 2 different types of sequential estrogen-gestagen preparations].
    Gam F; Helles A; Andersen B
    Ugeskr Laeger; 1977 Nov; 139(47):2808-12. PubMed ID: 339455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    Gynecol Endocrinol; 2005 Aug; 21(2):101-5. PubMed ID: 16109596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?
    Lobo RA; Whitehead MI
    Climacteric; 2001 Jun; 4(2):110-9. PubMed ID: 11428175
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding uncertainty.
    Ghosh AK
    Minn Med; 2003 Apr; 86(4):5-6. PubMed ID: 12797649
    [No Abstract]   [Full Text] [Related]  

  • 17. [The climacteric and its hormonal treatment].
    Gvorgiev DB
    Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone therapy and brain structure in postmenopausal women.
    Molano JR
    Neurology; 2016 Aug; 87(9):e100-2. PubMed ID: 27572433
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose and duration of hormone use: understanding the effects of combined menopausal hormones on breast cancer better, 1976-2004.
    McPherson K; Mant R
    J Epidemiol Community Health; 2005 Dec; 59(12):1078-9. PubMed ID: 16286498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.